Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Prevention of Antibiotic Associated Diarrhea and Clostridium difficile.
- 2018-04-26
- Clinical Trial
- Nutrients 10(5)
- Cathy Alberda
- Sam Marcushamer
- Tayne Hewer
- Nicole Journault
- Demetrios Kutsogiannis
- PubMed: 29701662
- DOI: 10.3390/nu10050539
- High evidence
- Rigorous Journal
- Clinical
AAD was documented in 12.5% of the probiotic group and 31.3% in the control group.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- two bottles daily of a drink containing 10 billion Lactobacillus casei